NVO logo

Novo Nordisk A/S (NVO) Working capital

annual working capital:

-$7.90B-$3.45B(-77.33%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual working capital is -$7.90 billion, with the most recent change of -$3.45 billion (-77.33%) on December 31, 2024.
  • During the last 3 years, NVO annual working capital has fallen by -$5.78 billion (-272.82%).
  • NVO annual working capital is now -313.38% below its all-time high of $3.70 billion, reached on December 31, 2009.

Performance

NVO Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly working capital:

-$8.95B-$1.05B(-13.32%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly working capital is -$8.95 billion, with the most recent change of -$1.05 billion (-13.32%) on March 31, 2025.
  • Over the past year, NVO quarterly working capital has dropped by -$1.84 billion (-25.84%).
  • NVO quarterly working capital is now -339.36% below its all-time high of $3.74 billion, reached on June 30, 2011.

Performance

NVO quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

NVO Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-77.3%-25.8%
3 y3 years-272.8%-558.2%
5 y5 years-1617.4%-10000.0%

NVO Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-330.7%at low-855.2%at low
5 y5-year-1617.4%at low-1042.8%at low
alltimeall time-313.4%at low-339.4%at low

NVO Working capital History

DateAnnualQuarterly
Mar 2025
-
-$8.95B(+13.3%)
Dec 2024
-$7.90B(+77.3%)
-$7.90B(+299.7%)
Sep 2024
-
-$1.98B(+32.3%)
Jun 2024
-
-$1.49B(-79.0%)
Mar 2024
-
-$7.11B(+59.7%)
Dec 2023
-$4.46B(+142.9%)
-$4.46B(+3.6%)
Sep 2023
-
-$4.30B(+54.5%)
Jun 2023
-
-$2.78B(+5.5%)
Mar 2023
-
-$2.64B(+43.8%)
Dec 2022
-$1.83B(-13.4%)
-$1.83B(+28.8%)
Sep 2022
-
-$1.42B(+51.9%)
Jun 2022
-
-$937.30M(-31.1%)
Mar 2022
-
-$1.36B(-35.8%)
Dec 2021
-$2.12B(+187.2%)
-$2.12B(-570.9%)
Sep 2021
-
$450.09M(-35.3%)
Jun 2021
-
$695.81M(-140.2%)
Mar 2021
-
-$1.73B(+134.9%)
Dec 2020
-$737.83M(-241.7%)
-$737.83M(-272.1%)
Sep 2020
-
$428.72M(-54.9%)
Jun 2020
-
$949.63M(>+9900.0%)
Mar 2020
-
$886.10K(-99.8%)
Dec 2019
$520.68M(-30.7%)
$520.68M(+1035.2%)
Sep 2019
-
$45.87M(-85.8%)
Jun 2019
-
$323.73M(-206.3%)
Mar 2019
-
-$304.47M(-140.5%)
Dec 2018
$751.09M(-64.2%)
$751.09M(+2.5%)
Sep 2018
-
$732.83M(-43.2%)
Jun 2018
-
$1.29B(+35.9%)
Mar 2018
-
$950.09M(-54.7%)
Dec 2017
$2.10B(+19.7%)
$2.10B(+10.8%)
Sep 2017
-
$1.89B(-18.7%)
Jun 2017
-
$2.33B(+140.5%)
Mar 2017
-
$968.92M(-44.7%)
Dec 2016
$1.75B(-16.1%)
$1.75B(+16.7%)
Sep 2016
-
$1.50B(-9.4%)
Jun 2016
-
$1.66B(+105.7%)
Mar 2016
-
$806.88M(-61.4%)
Dec 2015
$2.09B(+1.6%)
$2.09B(+6.9%)
Sep 2015
-
$1.96B(+48.8%)
Jun 2015
-
$1.31B(+516.0%)
Mar 2015
-
$213.40M(-89.6%)
Dec 2014
$2.06B(-37.7%)
$2.06B(+8.4%)
Sep 2014
-
$1.90B(-0.8%)
Jun 2014
-
$1.91B(+28.3%)
Mar 2014
-
$1.49B(-54.8%)
Dec 2013
$3.30B(+0.5%)
$3.30B(+19.6%)
Sep 2013
-
$2.76B(+42.2%)
Jun 2013
-
$1.94B(+11.0%)
Mar 2013
-
$1.75B(-46.7%)
Dec 2012
$3.28B
$3.28B(+29.3%)
Sep 2012
-
$2.54B(+25.8%)
Jun 2012
-
$2.02B(-21.4%)
DateAnnualQuarterly
Mar 2012
-
$2.57B(-21.6%)
Dec 2011
$3.28B(-2.3%)
$3.28B(-2.6%)
Sep 2011
-
$3.37B(-10.0%)
Jun 2011
-
$3.74B(+14.8%)
Mar 2011
-
$3.26B(-2.9%)
Dec 2010
$3.36B(-9.3%)
$3.36B(+8.1%)
Sep 2010
-
$3.11B(+22.2%)
Jun 2010
-
$2.54B(-11.6%)
Mar 2010
-
$2.88B(-22.3%)
Dec 2009
$3.70B(+22.2%)
$3.70B(+4.1%)
Sep 2009
-
$3.56B(+9.4%)
Jun 2009
-
$3.25B(+26.0%)
Mar 2009
-
$2.58B(-14.8%)
Dec 2008
$3.03B(+13.3%)
$3.03B(+8.3%)
Sep 2008
-
$2.80B(-12.8%)
Jun 2008
-
$3.21B(+15.7%)
Mar 2008
-
$2.78B(+3.8%)
Dec 2007
$2.67B(+41.6%)
$2.67B(+11.9%)
Sep 2007
-
$2.39B(+6.2%)
Jun 2007
-
$2.25B(+22.3%)
Mar 2007
-
$1.84B(-2.5%)
Dec 2006
$1.89B(+32.8%)
$1.89B(+23.1%)
Sep 2006
-
$1.54B(-11.1%)
Jun 2006
-
$1.73B(+27.3%)
Mar 2006
-
$1.36B(-4.6%)
Dec 2005
$1.42B(-25.9%)
$1.42B(-0.2%)
Sep 2005
-
$1.42B(+12.7%)
Jun 2005
-
$1.26B(-18.2%)
Mar 2005
-
$1.55B(-19.4%)
Dec 2004
$1.92B(+17.5%)
$1.92B(+24.0%)
Sep 2004
-
$1.55B(+6.4%)
Jun 2004
-
$1.45B(+6.6%)
Mar 2004
-
$1.36B(-16.5%)
Dec 2003
$1.63B(+48.5%)
$1.63B(+48.5%)
Dec 2002
$1.10B(+18.5%)
$1.10B(+18.5%)
Dec 2001
$928.65M(+21.9%)
$928.65M(+21.9%)
Dec 2000
$762.06M(-17.9%)
$762.06M(-17.9%)
Dec 1999
$927.97M(-21.8%)
$927.97M(-21.8%)
Dec 1998
$1.19B(+7.5%)
$1.19B(+7.5%)
Dec 1997
$1.10B(+7.9%)
$1.10B(+7.9%)
Dec 1996
$1.02B(-0.3%)
$1.02B(-0.3%)
Dec 1995
$1.03B(-27.6%)
$1.03B(-27.6%)
Dec 1994
$1.42B(+74.2%)
$1.42B(+74.2%)
Dec 1993
$813.89M(-28.8%)
$813.89M(-28.8%)
Dec 1992
$1.14B(+46.0%)
$1.14B(+46.0%)
Dec 1991
$783.22M(+83.4%)
$783.22M(+83.4%)
Dec 1990
$427.06M(+2.9%)
$427.06M(+2.9%)
Dec 1989
$415.11M(+32.0%)
$415.11M(+32.0%)
Dec 1988
$314.45M(-7.5%)
$314.45M(-7.5%)
Dec 1987
$339.96M(+16.1%)
$339.96M(+16.1%)
Dec 1986
$292.90M(-2.2%)
$292.90M(-2.2%)
Dec 1985
$299.51M(+37.9%)
$299.51M(+37.9%)
Dec 1984
$217.20M
$217.20M

FAQ

  • What is Novo Nordisk A/S annual working capital?
  • What is the all time high annual working capital for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual working capital year-on-year change?
  • What is Novo Nordisk A/S quarterly working capital?
  • What is the all time high quarterly working capital for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly working capital year-on-year change?

What is Novo Nordisk A/S annual working capital?

The current annual working capital of NVO is -$7.90B

What is the all time high annual working capital for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual working capital is $3.70B

What is Novo Nordisk A/S annual working capital year-on-year change?

Over the past year, NVO annual working capital has changed by -$3.45B (-77.33%)

What is Novo Nordisk A/S quarterly working capital?

The current quarterly working capital of NVO is -$8.95B

What is the all time high quarterly working capital for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly working capital is $3.74B

What is Novo Nordisk A/S quarterly working capital year-on-year change?

Over the past year, NVO quarterly working capital has changed by -$1.84B (-25.84%)
On this page